LEXICON PHARMACEUTICALS INC - COM (LXRX)

CUSIP: 528872104

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
688,037,952
Share change
+219,450,295
Total reported value
$626,084,857
Price per share
$0.91
Number of holders
118
Value change
+$199,490,338
Number of buys
74
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 528872104?
CUSIP 528872104 identifies LXRX - LEXICON PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LEXICON PHARMACEUTICALS INC - COM (LXRX) as of Q4 2014

As of 31 Dec 2014, LEXICON PHARMACEUTICALS INC - COM (LXRX) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 688,037,952 shares. The largest 10 holders included Artal Group S.A., FMR LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, Ulys, L.L.C., VANGUARD GROUP INC, NEA Management Company, LLC, BlackRock Fund Advisors, MASTERS CAPITAL MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 118 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.